Silenced effector functions can be obtained by mutation in the Fc constant part of the antibodies and have been described in the Art: Strohl 2009 (AA & N297A)
First, it stimulates lipolysis, which is the breakdown of stored fat into free fatty acids the body can use as fuel
CGRP stimulates the proliferation and differentiation of osteoprogenitor cells while reducing their apoptosis
Landscapes Health & Medical Sciences (AREA) Bioinformatics & Cheminformatics (AREA) Engineering & Computer Science (AREA) Chemical & Material Sciences (AREA) Life Sciences & Earth Sciences (AREA) General Health & Medical Sciences (AREA) Medicinal Chemistry (AREA) Immunology (AREA) Veterinary Medicine (AREA) Public Health (AREA) Animal Behavior & Ethology (AREA) Pharmacology & Pharmacy (AREA) Organic Chemistry (AREA) Epidemiology (AREA) Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA) Cell Biology (AREA) Chemical Kinetics & Catalysis (AREA) General Chemical & Material Sciences (AREA) Biophysics (AREA) Molecular Biology (AREA) Genetics & Genomics (AREA) Proteomics, Peptides & Aminoacids (AREA) Biochemistry (AREA) Oncology (AREA) Peptides Or Proteins (AREA) Medicinal Preparation (AREA) Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA) Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA) Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA) Abstract The present invention relates to antibody-drug conjugates, wherein the antibody specifically binds to folate receptor a, and wherein the drug is preferably chosen among a cytotoxic drug
In a typical 80 mg vial, that breaks down to GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg, and KPV 10 mg
10.1039/c6cs00052e 71 HurlbertR
